EPIX Dividend: ESSA Pharma Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

EPIX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	09/30/2024	09/30/2023	09/30/2022	09/30/2021	09/30/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0
Selling, General & Admin	17	13	11	12	12	11
Research & Development	12	21	21	24	24	12
Operating Expenses	29	34	32	36	37	23
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-25	-28	-26	-35	-36	-23
Income Tax Expense	--	0	0	0	0	0
Net Income	-25	-28	-26	-35	-36	-23
Net Income Growth	-7%	8%	-26%	-3%	56.99%	92%
Shares Outstanding (Diluted)	44.38	44.27	44.08	44.04	38.48	22.44
Shares Change (YoY)	0%	0%	0%	14%	71%	166%
EPS (Diluted)	-0.56	-0.64	-0.6	-0.8	-0.96	-1.04
EPS Growth	-10%	7%	-25%	-17%	-8%	-31%
Free Cash Flow	-20	-22	-19	-28	-25	-16
Free Cash Flow Per Share	-0.45	-0.49	-0.43	-0.63	-0.64	-0.71
Gross Margin	0%	0%	0%	0%	0%	0%
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-29	-34	-32	--	--	--
EBITDA Margin	0%	0%	0%	--	--	--
D&A For EBITDA	0	0	0	--	--	--
EBIT	-29	-34	-32	-36	-37	-23
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	0%	0%	0%	0%